Loading
Total declarations
Company
▲ Purchases (5 ops.)
▼ Sales (0 ops.)
Latest filing published 17 Jun 2026 for Clover Biopharmaceuticals, Ltd. - B.
Insider track record
Disclosed buys
5
Disclosed sells
0
Signal history
No signal scores available.
Closed purchases
Market purchases
1
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Since each purchase
- -35.4%Entry HK$2.85 · Close 05 Oct 2026 HK$1.84
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
AMBROSINO Donna Marie: trading record in brief
AMBROSINO Donna Marie is a declared insider of Clover Biopharmaceuticals, Ltd. - B (chief executive), with filings sourced from HKEX. The record holds 46 filings, for trades running from 17 June 2022 to 15 June 2026.
Every open-market trade on record is a purchase: 5 purchases, and no sale. The totals exclude 5 filings filed without an amount. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. So far in 2026, the count stands at 1 purchase and no sales.
The record was last updated on 17 June 2026 with a transaction in Clover Biopharmaceuticals, Ltd. - B. The clock since the last published purchase (1 April 2026) now reads 206 days. Typically, a trade is published a median of 3 days after it takes place. That lag is the time during which only the insider knows about the trade. These figures are compiled from regulatory filings published by HKEX. They describe what insiders did and are not a recommendation.
Companies and markets linked to AMBROSINO Donna Marie
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations3 total
14,500 sharesShareXHKGHKEX:DA20260617E00208
49,000 sharesShareXHKGHKEX:DA20260409E00086
340,000 sharesShareXHKGHKEX:DA20260401E00045
Canonical exit: 25 Jun 2026 (T+90)
3 of 3 declarations
